Performing the ABC Method Twice for Gastric Cancer Risk Stratification: A Retrospective Study Based on Data from a Large-Scale Screening Facility

被引:1
作者
Mizutani, Satoru [1 ]
Takahashi, Yu [1 ]
Shimamoto, Takeshi [2 ]
Nakagawa, Hideki [1 ]
Hisada, Hiroyuki [1 ]
Oshio, Kaori [1 ]
Kubota, Dai [1 ]
Mizutani, Hiroya [1 ,3 ]
Ohki, Daisuke [1 ,4 ]
Sakaguchi, Yoshiki [1 ]
Yakabi, Seiichi [1 ,5 ]
Niimi, Keiko [1 ,6 ]
Kakushima, Naomi [1 ,7 ]
Tsuji, Yosuke [1 ,3 ]
Wada, Ryoichi [2 ]
Yamamichi, Nobutake [1 ,6 ]
Fujishiro, Mitsuhiro [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138655, Japan
[2] Kameda Med Ctr Makuhari CD 2F, 1 3 Nakase,Mihama ku, Chiba, Chiba 2618501, Japan
[3] Univ Tokyo, Grad Sch Med, Next Generat Endoscop Comp Vis, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138655, Japan
[4] Univ Tokyo, Grad Sch Med, Infect Control & Prevent Serv, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138655, Japan
[5] Univ Tokyo, Ctr Int Prevent Med, Grad Sch Med, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138655, Japan
[6] Univ Tokyo, Ctr Epidemiol & Prevent Med, Grad Sch Med, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138655, Japan
[7] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138655, Japan
基金
日本学术振兴会;
关键词
ABC method; gastric cancer; H; pylori; pepsinogen; risk stratification; HELICOBACTER-PYLORI INFECTION; SERUM PEPSINOGEN; ANTIBODIES; SEROCONVERSION; METAANALYSIS; COMBINATION; PREVALENCE; PERIOD; TITER; AGE;
D O I
10.3390/diagnostics13071284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ABC method is a classification method used for stratifying the risk of gastric cancer. However, whether the ABC method should be performed only once or multiple times throughout an individual's lifetime remains unclear. Therefore, this study aimed to analyze whether performing ABC screening twice in a lifetime is useful. We retrospectively analyzed the data of individuals who participated in health checkups in 2010 and 2015. We collected data on patient characteristics, pepsinogen levels, anti-Helicobacter pylori antibody titers, and the presence of gastric cancer. Overall, 7129 participants without a history of H. pylori eradication were included in this study. The participants' average age in 2010 was 48.4 +/- 8.3 years, and 58.1% were male. In addition, 11 and 20 cases of new H. pylori infection (0.15%) and spontaneous eradication (0.28%), respectively, were recorded. No significant difference was found in the incidence of gastric cancer between participants who underwent the ABC method once and those who underwent it twice (Group A: 0.16% vs. 0.16%; Group B: 0.47% vs. 0.39%; and Group C + D: 1.97% vs. 1.82%). Therefore, performing the ABC method twice, 5 years apart, does not significantly improve gastric cancer risk stratification.
引用
收藏
页数:11
相关论文
共 29 条
  • [1] Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection
    Daugule, Ilva
    Ruskule, Agnese
    Moisejevs, Georgijs
    Rudzite, Dace
    Jonaitis, Laimas
    Janciauskas, Dainius
    Kiudelis, Gediminas
    Kupcinskas, Limas
    Leja, Marcis
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (05) : 501 - 505
  • [2] Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26
    Fawcett, J. Paul
    Barbezat, Gill O.
    Poulton, Richie
    Milne, Barry J.
    Xia, Harry H. X.
    Talley, Nicholas J.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (21) : 3273 - 3276
  • [3] Analysis of long-term serological and histological changes after eradication of Helicobacter pylori
    Fukuda, Kensuke
    Kodama, Masaaki
    Mizukami, Kazuhiro
    Okamoto, Kazuhisa
    Ogawa, Ryo
    Hirashita, Yuka
    Fukuda, Masahide
    Togo, Kazumi
    Matsunari, Osamu
    Okimoto, Tadayoshi
    Murakami, Kazunari
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2022, 71 (02) : 151 - 157
  • [4] Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori
    Hu, Y.
    Wan, J. -H.
    Li, X. -Y.
    Zhu, Y.
    Graham, D. Y.
    Lu, N. -H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (09) : 773 - 779
  • [5] Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study
    Ikeda, Fumie
    Shikata, Kentaro
    Hata, Jun
    Fukuhara, Masayo
    Hirakawa, Yoichiro
    Ohara, Tomoyuki
    Mukai, Naoko
    Nagata, Masaharu
    Yoshida, Daigo
    Yonemoto, Koji
    Esaki, Motohiro
    Kitazono, Takanari
    Kiyohara, Yutaka
    Ninomiya, Toshiharu
    [J]. JOURNAL OF EPIDEMIOLOGY, 2016, 26 (12) : 629 - 636
  • [6] Inaba S, 1999, PREV MED, V29, P102
  • [7] Seroconversion Rates of Helicobacter pylori Infection in Korean Adults
    Jung, Ji Hoon
    Choi, Kee Don
    Han, Seungbong
    Jung, Hwoon-Yong
    Do, Mi Young
    Chang, Hye-Sook
    Choe, Jae-Won
    Lee, Gin Hyug
    Song, Ho June
    Kim, Do Hoon
    Choi, Kwi-Sook
    Lee, Jeong Hoon
    Ahn, Ji Yong
    Kim, Mi-Young
    Bae, Suh Eun
    Kim, Jin-Ho
    [J]. HELICOBACTER, 2013, 18 (04) : 299 - 308
  • [8] Seroconversion and seroreversion of Helicobacter pylori antibodies over a 9-year period and related factors in Japanese adults
    Kikuchi, S
    Ohgihara, A
    Hasegawa, A
    Miki, K
    Kaneko, E
    Mizukoshi, H
    [J]. HELICOBACTER, 2004, 9 (04) : 335 - 341
  • [9] Helicobacter pylori Antibody Titer and Gastric Cancer Screening
    Kishikawa, Hiroshi
    Kimura, Kayoko
    Takarabe, Sakiko
    Kaida, Shogo
    Nishida, Jiro
    [J]. DISEASE MARKERS, 2015, 2015 : 1 - 11
  • [10] LONG-TERM SEQUELAE OF HELICOBACTER-PYLORI GASTRITIS
    KUIPERS, EJ
    UYTERLINDE, AM
    PENA, AS
    ROOSENDAAL, R
    PALS, G
    NELIS, GF
    FESTEN, HPM
    MEUWISSEN, SGM
    [J]. LANCET, 1995, 345 (8964): : 1525 - 1528